Back

Prevalence of multiple native valvular heart disease in TAVR patients: a multicenter study assessing the impact of staged transcatheter edge-to-edge repair

1 September 2024 (15:45 - 15:55)
Organised by: Logo
Congress Presentation Part of: The 50 shades of TAVI Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Baravan Al-Kassou

University hospital Bonn, Bonn (Germany)

5 More presentations in this session

Presentation thumbnail
Transcatheter valve replacement as rescue treatment for heart failure in infective endocarditis. A multinational series.
Doctor N. Fernandez Hidalgo (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching
Doctor M. Boute (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Two different hybrid vascular access closure strategies post transcatheter aortic valve implantation
Doctor M. Abdelaziz (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Outcomes of percutaneous coronary interventions after transcatheter aortic valve replacement
Doctor C. Pivato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Independent association between radial secondary access and stroke in patients undergoing transcatheter aortic valve implantation
Doctor M. Potratz (Bad Oeynhausen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
The 50 shades of TAVI
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 15:45 CET
You may be interested in
thumbnail
Congress Presentation
Incidence and management of multiple native valvular heart disease in patients undergoing TAVR: Impact of staged valvular interventions on outcomes
thumbnail
Congress Presentation
Characteristics and outcomes of patients with moderate multivalvular disease in the context of tricuspid regurgitation
thumbnail
Congress Presentation
Challenges of multivalvular heart disease for the cardiologist

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources